CBT vs ERT for Cancer Caregivers

Not currently recruiting at 4 trial locations
WB
AA
Overseen ByAllison Applebaum, PhD
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: Memorial Sloan Kettering Cancer Center
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

This trial aims to compare two therapies for caregivers of cancer patients: Cognitive Behavioral Therapy for Cancer Caregivers (CBT-C) and Emotion Regulation Therapy for Cancer Caregivers (ERT-C). The goal is to determine if ERT-C reduces caregiver stress, anxiety, and depression more effectively than CBT-C. Researchers will also examine how these therapies affect caregivers' hormone and stress levels and the quality of life for the cancer patients they support. Caregivers experiencing significant stress related to assisting someone with cancer and residing in New York, New Jersey, or Massachusetts may be interested in participating. As an unphased trial, this study offers caregivers the opportunity to explore new therapeutic options that could enhance their well-being and the quality of life for those they support.

Will I have to stop taking my current medications?

The trial does not specify if you need to stop taking your current medications. However, if you have a medical condition or take medications that affect inflammation, you may not be eligible to participate.

What prior data suggests that these therapies are safe for caregivers?

Research has shown that both Emotion Regulation Therapy for Cancer Caregivers (ERT-C) and Cognitive Behavioral Therapy for Cancer Caregivers (CBT-C) are safe for participants.

Studies have found that individuals who try ERT-C generally tolerate it well. Participants who completed ERT-C reported reduced depression and anxiety, experienced fewer negative thoughts, and gained better control over their emotions. This indicates that ERT-C is not only safe but also effective for managing stress.

CBT-C is also safe and has proven effective in reducing anxiety and depression in caregivers. It enhances resilience, enabling caregivers to better cope with stress and challenges. Research has also shown that CBT-C reduces fatigue in cancer patients, highlighting its broad benefits.

Overall, both therapies have been tested in various settings with positive results. As non-drug treatments, they avoid the side effects associated with medications, making them well-tolerated options for caregivers seeking to manage stress and improve their quality of life.12345

Why are researchers excited about this trial?

Researchers are excited about these therapies because they offer innovative approaches to supporting cancer caregivers. Unlike standard treatments that typically focus on managing stress and providing general support, Cognitive Behavioral Therapy for Cancer Caregivers (CBT-C) specifically aims to transform negative thought patterns and behaviors. Emotion Regulation Therapy for Cancer Caregivers (ERT-C) takes it further by enhancing emotional processing and regulation, addressing both early and late stages of emotional distress. These therapies are promising because they not only target the caregivers' immediate stress but also equip them with long-term coping strategies, potentially leading to more sustainable well-being improvements.

What evidence suggests that this trial's therapies could be effective for cancer caregivers?

Research has shown that Cognitive Behavioral Therapy for Cancer Caregivers (CBT-C), one of the therapies studied in this trial, can reduce depression and anxiety in those caring for cancer patients. Although it may not significantly enhance overall quality of life, it provides emotional benefits. Emotion Regulation Therapy for Cancer Caregivers (ERT-C), another therapy under study, also appears promising. It reduces depression, anxiety, and negative thoughts. ERT-C improves caregivers' emotional management, offering valuable support. Both therapies could effectively reduce caregiver stress.26789

Who Is on the Research Team?

Christian J. Nelson, PhD - MSK Psychologist

Christian Nelson, PhD

Principal Investigator

Memorial Sloan Kettering Cancer Center

Are You a Good Fit for This Trial?

This trial is for adult caregivers in New York, New Jersey, or Massachusetts who speak English very well and are caring for a cancer patient treated within the last year. Caregivers must be experiencing distress related to their role. Patients also participate if they're adults, fluent in English, and cared for by an eligible caregiver.

Inclusion Criteria

Caregivers:
I am a close contact of a cancer patient who has been treated in the last year.
Patient of an eligible IC per self-report or the EMR.
See 8 more

Exclusion Criteria

As per self-report, currently enrolled in another study focused on supportive care for caregivers (MGH participants only).
As per self-report, presence of disorder that compromises comprehension of assessments or informed consent information (e.g., dementia).
Presence of disorder that compromises comprehension of assessments or informed consent information (e.g., dementia) as per EMR or clinician judgment.
See 6 more

Timeline for a Trial Participant

Screening

Participants are screened for eligibility to participate in the trial

2-4 weeks

Treatment

Participants receive either Emotion Regulation Therapy for Cancer Caregivers (ERT-C) or Cognitive Behavioral Therapy (CBT-C) over 8 sessions

8-16 weeks
8 sessions (telepsychiatry)

Follow-up

Participants are monitored for changes in anxiety and depressive symptoms

up to 6 months

What Are the Treatments Tested in This Trial?

Interventions

  • Cognitive Behavioral Therapy for Cancer Caregivers (CBT-C)
  • Emotion Regulation Therapy for Cancer Caregivers (ERT-C)
Trial Overview The study compares Emotion Regulation Therapy (ERT-C) with Cognitive Behavioral Therapy (CBT-C) to see which better reduces caregiver distress. It measures anxiety, depression, quality of life of caregivers and patients' stress levels through saliva samples.
How Is the Trial Designed?
3Treatment groups
Experimental Treatment
Group I: Training case groupExperimental Treatment1 Intervention
Group II: ERT-C: Emotion Regulation Therapy for Cancer CaregiversExperimental Treatment1 Intervention
Group III: CBT-C: Cognitive Behavioral Therapy for Cancer CaregiversExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

Memorial Sloan Kettering Cancer Center

Lead Sponsor

Trials
1,998
Recruited
602,000+

Columbia University

Collaborator

Trials
1,529
Recruited
2,832,000+

University of Aarhus

Collaborator

Trials
1,441
Recruited
14,600,000+

University of Michigan

Collaborator

Trials
1,891
Recruited
6,458,000+

University of California

Collaborator

Trials
46
Recruited
208,000+

Published Research Related to This Trial

Emotion Regulation Therapy adapted for cancer informal caregivers (ERT-C) was well tolerated and showed promising initial efficacy, with 31 participants completing eight weekly sessions and reporting significant reductions in depression, anxiety, and perseverative negative thinking (PNT).
Despite the reduction in emotional distress, caregiver burden remained unchanged; however, participants felt more capable of facing caregiving challenges, indicating that ERT-C may help improve coping strategies for informal caregivers.
Emotion regulation therapy for cancer caregivers-an open trial of a mechanism-targeted approach to addressing caregiver distress.Applebaum, AJ., Panjwani, AA., Buda, K., et al.[2021]
A multi-site randomized trial is being conducted with 200 family caregivers of cancer patients to compare the effectiveness of two adapted therapies, Emotion Regulation Therapy for Caregivers (ERT-C) and Cognitive Behavioral Therapy for Caregivers (CBT-C), in reducing caregiver distress.
The study aims to assess not only the psychological outcomes like anxiety and depression but also the impact of these interventions on the caregivers' quality of life and potential biological markers of stress, providing a comprehensive understanding of caregiver support needs.
A randomized controlled trial of emotion regulation therapy for cancer caregivers: A mechanism-targeted approach to addressing caregiver distress.Applebaum, AJ., Loschiavo, M., Morgan, K., et al.[2023]
In a randomized controlled trial involving 81 informal caregivers, Emotion Regulation Therapy adapted for caregivers (ERT-C) significantly reduced psychological distress, worry, and caregiver burden, with medium to large effect sizes, particularly post-treatment.
Caregivers who participated in ERT-C also reported a large increase in quality of life for themselves and the cancer patients they cared for, highlighting the therapy's potential benefits in comprehensive cancer care.
A Randomized Controlled Trial of Emotion Regulation Therapy for Psychologically Distressed Caregivers of Cancer Patients.O'Toole, MS., Mennin, DS., Applebaum, A., et al.[2022]

Citations

A meta-analysis of the effects of cognitive behavioral ...CBT had a positive effect on reducing depression and anxiety in informal cancer caregivers, and the effect on quality of life was not statistically significant.
Third-wave cognitive behavioral therapies for caregivers of ...The current review explored available third-wave CBT intervention studies for cancer caregivers and targeted outcomes.
Internet-Based Cognitive Behavioral Therapy Interventions ...Outcome indicators encompassed feasibility and acceptability, anxiety, depression, caregiver burden, and quality of life. ICBT demonstrated.
A randomized controlled trial of emotion regulation therapy ...Cognitive behavioral therapy (CBT), an effective therapy for anxiety and depression, has shown mixed efficacy when delivered to cancer caregivers. Emotion ...
Effects of cognitive behavioral therapy on resilience among ...The results of this study indicate CBT can improve resilience among cancer patients. These findings underscore the importance of considering ...
The effect of cognitive behavioral therapy on chemotherapy ...However, as a non-pharmaceutical treatment, it remains unclear whether CBT improves chemotherapy-induced side effects and immune function in CRC patients.
Cognitive behavioral therapies for informal caregivers of ...Cognitive behavioral therapies (CBTs) have been found to be effective in treating individuals presenting with symptoms of anxiety and depression ...
Effect of cognitive-behavioral therapy on fatigue in cancer ...The current systematic review and meta-analysis encompasses 10 RCTs. CBT demonstrated a significant reduction in fatigue scores among cancer patients.
Original Article Cognitive behavioral therapy or graded ...Cognitive behavioral therapy (CBT) reduced fatigue in severely fatigued patients receiving cancer treatment with palliative intent.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Terms of Service·Privacy Policy·Cookies·Security